{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:19:22Z","timestamp":1792696762284,"version":"4.5.0"},"reference-count":83,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>During the SARS-CoV-2 pandemic, a higher incidence of invasive pulmonary aspergillosis was observed in patients affected by Coronavirus disease 2019 (COVID-19), leading to the delineation of a new entity named COVID-19 associated pulmonary aspergillosis (CAPA). A predisposition to invasive infection caused by Aspergillus spp. in SARS-CoV-2 infected patients can be ascribed either to the direct viral-mediated damage of the respiratory epithelium, as already observed in influenza H1N1 virus infections, or to the dysregulated immunity associated with COVID-19. This narrative review focuses on the impact of immune impairment, particularly due to cytokine dysregulation caused by Aspergillus spp. superinfection in COVID-19 for a more in-depth understanding of the molecular pathways implicated in CAPA. As immune competence has proven to be essential in protecting against CAPA onset, a role already threatened by SARS-CoV-2 infection itself, preventive strategies should focus on reducing factors that could further target the host immune system. We also aimed to focus on well-known and less-known risk factors for IPA in COVID-19 patients, related to the main causes of immune suppression, both virus-mediated and iatrogenic, including treatments currently indicated for COVID-19. Lastly, possible preventive strategies aimed at reducing morbidity and mortality due to CAPA could be implemented.<\/jats:p>","DOI":"10.3390\/diagnostics12061364","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T12:48:31Z","timestamp":1654087711000},"page":"1364","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cytokine Profile of Invasive Pulmonary Aspergillosis in Severe COVID-19 and Possible Therapeutic Targets"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3846-4620","authenticated-orcid":false,"given":"Alessandro","family":"Russo","sequence":"first","affiliation":[{"name":"Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, \u201cMagna Graecia\u201d University of Catanzaro, Viale Europa, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Linda","family":"Morrone","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, \u201cMagna Graecia\u201d University of Catanzaro, Viale Europa, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Rotundo","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, \u201cMagna Graecia\u201d University of Catanzaro, Viale Europa, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9064-7745","authenticated-orcid":false,"given":"Enrico Maria","family":"Trecarichi","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, \u201cMagna Graecia\u201d University of Catanzaro, Viale Europa, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7631-5453","authenticated-orcid":false,"given":"Carlo","family":"Torti","sequence":"additional","affiliation":[{"name":"Infectious and Tropical Disease Unit, Department of Medical and Surgical Sciences, \u201cMagna Graecia\u201d University of Catanzaro, Viale Europa, 88100 Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Xu, J., Zhao, S., Teng, T., Abdalla, A.E., Zhu, W., Xie, L., Wang, Y., and Guo, X. (2020). Systematic Comparison of Two Animal-to-Human Transmitted Human Coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses, 12.","DOI":"10.3390\/v12020244"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Ravid, J.D., Leiva, O., and Chitalia, V.C. (2022). Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations. Cells, 11.","DOI":"10.3390\/cells11020306"},{"key":"ref_3","first-page":"2459","article-title":"Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing","volume":"71","author":"Rawson","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13054-021-03460-5","article-title":"Ventilator-associated pneumonia in critically ill patients with COVID-19","volume":"25","author":"Maes","year":"2021","journal-title":"Crit. Care"},{"key":"ref_5","first-page":"48","article-title":"Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19","volume":"69","year":"2021","journal-title":"Rev. Esp. Anestesiol. Reanim."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/S2213-2600(20)30237-X","article-title":"Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19","volume":"8","author":"Alanio","year":"2020","journal-title":"Lancet. Respir. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/s00134-012-2673-2","article-title":"Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: A retrospective study","volume":"38","author":"Wauters","year":"2012","journal-title":"Intensive Care Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","article-title":"Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer\/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC\/MSG) Consensus Group","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e149","DOI":"10.1016\/S1473-3099(20)30847-1","article-title":"Defining and managing COVID-19-associated pulmonary aspergillosis: The 2020 ECMM\/ISHAM consensus criteria for research and clinical guidance","volume":"21","author":"Koehler","year":"2021","journal-title":"Lancet Infect. Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"406","DOI":"10.3109\/13693786.2010.535030","article-title":"Invasive aspergillosis in patients with liver disease","volume":"49","author":"Falcone","year":"2011","journal-title":"Med. Mycol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00134-021-06449-4","article-title":"Taskforce report on the diagnosis and clinical management of COVID-19 associated pulmonary aspergillosis","volume":"47","author":"Verweij","year":"2021","journal-title":"Intensive Care Med."},{"key":"ref_12","first-page":"1631","article-title":"Navigating the uncertainties of COVID-19 associated aspergillosis (CAPA): A comparison with influenza associated aspergillosis (IAPA)","volume":"10","author":"Lamoth","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e405","DOI":"10.1016\/S2666-5247(21)00091-4","article-title":"Invasive mould disease in fatal COVID-19: A systematic review of autopsies","volume":"2","author":"Kula","year":"2021","journal-title":"Lancet Microbe"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e0122921","DOI":"10.1128\/JCM.01229-21","article-title":"Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients","volume":"59","author":"Ergun","year":"2021","journal-title":"J. Clin. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s40121-020-00315-4","article-title":"Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment","volume":"9","author":"Russo","year":"2020","journal-title":"Infect. Dis. Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-alpha and IFN-gamma Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.blre.2014.03.002","article-title":"Hemophagocytic syndromes--an update","volume":"28","author":"Janka","year":"2014","journal-title":"Blood Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cytogfr.2020.05.009","article-title":"IL-6: Relevance for immunopathology of SARS-CoV-2","volume":"53","author":"Gubernatorova","year":"2020","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-020-1051-9","article-title":"An inflammatory cytokine signature predicts COVID-19 severity and survival","volume":"26","author":"Huang","year":"2020","journal-title":"Nat. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front. Immunol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zhao, J., Zhao, J., Van Rooijen, N., and Perlman, S. (2009). Evasion by stealth: Inefficient immune activation underlies poor T cell response and severe disease in SARS-CoV-infected mice. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000636"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fimmu.2013.00391","article-title":"The Interleukin-1alpha Precursor is Biologically Active and is Likely a Key Alarmin in the IL-1 Family of Cytokines","volume":"4","author":"Kim","year":"2013","journal-title":"Front. Immunol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1164\/ajrccm.164.10.2104013","article-title":"Cytokine balance in the lungs of patients with acute respiratory distress syndrome","volume":"164","author":"Park","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1172\/JCI137244","article-title":"Clinical and immunological features of severe and moderate coronavirus disease 2019","volume":"130","author":"Chen","year":"2020","journal-title":"J. Clin. Investig."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"102452","DOI":"10.1016\/j.jaut.2020.102452","article-title":"Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?","volume":"111","author":"Liu","year":"2020","journal-title":"J. Autoimmun."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/jmv.25948","article-title":"Elevated interleukin-6 and severe COVID-19: A meta-analysis","volume":"92","author":"Aziz","year":"2020","journal-title":"J. Med. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e150862","DOI":"10.1172\/jci.insight.150862","article-title":"Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19","volume":"6","author":"Kaiser","year":"2021","journal-title":"JCI Insight"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1038\/nri2711","article-title":"The regulation of IL-10 production by immune cells","volume":"10","author":"Saraiva","year":"2010","journal-title":"Nat. Rev. Immunol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"21244","DOI":"10.1038\/srep21244","article-title":"Hyporesponsiveness to the anti-inflammatory action of interleukin-10 in type 2 diabetes","volume":"6","author":"Barry","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.it.2020.10.012","article-title":"A Potential Role of Interleukin 10 in COVID-19 Pathogenesis","volume":"42","author":"Lu","year":"2021","journal-title":"Trends Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/QCO.0000000000000381","article-title":"Immune responses to invasive aspergillosis: New understanding and therapeutic opportunities","volume":"30","author":"Hohl","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1086\/656527","article-title":"Early proinflammatory cytokines and C-reactive protein trends as predictors of outcome in invasive Aspergillosis","volume":"202","author":"Chai","year":"2010","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJM200104053441415","article-title":"Invasive pulmonary aspergillosis associated with infliximab therapy","volume":"344","author":"Warris","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.4049\/jimmunol.162.3.1633","article-title":"Role of TNF-alpha in pulmonary host defense in murine invasive aspergillosis","volume":"162","author":"Mehrad","year":"1999","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1093\/infdis\/172.6.1554","article-title":"Interferon-gamma and tumor necrosis factor-alpha protect mice from invasive aspergillosis","volume":"172","author":"Nagai","year":"1995","journal-title":"J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/315027","article-title":"Proteases from Aspergillus fumigatus induce interleukin (IL)-6 and IL-8 production in airway epithelial cell lines by transcriptional mechanisms","volume":"180","author":"Borger","year":"1999","journal-title":"J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1046\/j.1365-2249.2000.01382.x","article-title":"Role of IL-10 in invasive aspergillosis: Increased resistance of IL-10 gene knockout mice to lethal systemic aspergillosis","volume":"122","author":"Clemons","year":"2000","journal-title":"Clin. Exp. Immunol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4049\/jimmunol.158.1.322","article-title":"IL-10 exerts suppressive and enhancing effects on antifungal activity of mononuclear phagocytes against Aspergillus fumigatus","volume":"158","author":"Roilides","year":"1997","journal-title":"J. Immunol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1016\/j.jaci.2017.02.034","article-title":"IL-10 overexpression predisposes to invasive aspergillosis by suppressing antifungal immunity","volume":"140","author":"Cunha","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/jim-2021-001857","article-title":"Diagnosis values of IL-6 and IL-8 levels in serum and bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in chronic obstructive pulmonary disease","volume":"69","author":"Liu","year":"2021","journal-title":"J. Investig. Med."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/infdis\/jiu381","article-title":"Interleukin 17 expression in peripheral blood neutrophils from fungal keratitis patients and healthy cohorts in southern India","volume":"211","author":"Karthikeyan","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1080\/13693780500052099","article-title":"Cytokines in host defense against Aspergillus: Recent advances","volume":"43","author":"Phadke","year":"2005","journal-title":"Med. Mycol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1093\/cid\/ciu1154","article-title":"Common severe infections in chronic granulomatous disease","volume":"60","author":"Marciano","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1086\/526500","article-title":"Polymorphisms in toll-like receptor genes and susceptibility to pulmonary aspergillosis","volume":"197","author":"Carvalho","year":"2008","journal-title":"J. Infect. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"O960","DOI":"10.1111\/1469-0691.12643","article-title":"Reduced expression of TLR3, TLR10 and TREM1 by human macrophages in Chronic cavitary pulmonary aspergillosis, and novel associations of VEGFA, DENND1B and PLAT","volume":"20","author":"Smith","year":"2014","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1515\/CCLM.2007.033","article-title":"Distinct alleles of mannose-binding lectin (MBL) and surfactant proteins A (SP-A) in patients with chronic cavitary pulmonary aspergillosis and allergic bronchopulmonary aspergillosis","volume":"45","author":"Vaid","year":"2007","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/cbin.11572","article-title":"Genetic and epigenetic factors associated with increased severity of COVID-19","volume":"45","author":"Yildirim","year":"2021","journal-title":"Cell Biol. Int."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S2213-2600(21)00138-7","article-title":"COVID-19-associated Aspergillus tracheobronchitis: The interplay between viral tropism, host defence, and fungal invasion","volume":"9","author":"Bruggemann","year":"2021","journal-title":"Lancet Respir. Med."},{"key":"ref_51","unstructured":"(2021). Coronavirus Disease 2019 (COVID-19) Treatment Guidelines."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1574-695X.2002.tb00549.x","article-title":"Kinetics of cytokine expression in mice with invasive aspergillosis: Lethal infection and protection","volume":"32","author":"Silveira","year":"2002","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1128\/IAI.73.1.494-503.2005","article-title":"Differences in patterns of infection and inflammation for corticosteroid treatment and chemotherapy in experimental invasive pulmonary aspergillosis","volume":"73","author":"Balloy","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1099\/13500872-140-9-2475","article-title":"Hydrocortisone-enhanced growth of Aspergillus spp.: Implications for pathogenesis","volume":"140","author":"Ng","year":"1994","journal-title":"Microbiology (Reading)"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/S0140-6736(03)14904-5","article-title":"Glucocorticoids and invasive fungal infections","volume":"362","author":"Lionakis","year":"2003","journal-title":"Lancet"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"753659","DOI":"10.3389\/fmed.2021.753659","article-title":"Risk Factors for Invasive Aspergillosis in Patients Admitted to the Intensive Care Unit With Coronavirus Disease 2019: A Multicenter Retrospective Study","volume":"8","author":"Xu","year":"2021","journal-title":"Front. Med."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"790-e1","DOI":"10.1016\/j.cmi.2020.12.005","article-title":"Risk factors associated with COVID-19-associated pulmonary aspergillosis in ICU patients: A French multicentric retrospective cohort","volume":"27","author":"Delliere","year":"2020","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0140-6736(20)31863-8","article-title":"Azithromycin for severe COVID-19","volume":"396","author":"Oldenburg","year":"2020","journal-title":"Lancet"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"e28722","DOI":"10.1097\/MD.0000000000028722","article-title":"SARS-CoV-2 (COVID-19) pneumonia patient treated with two doses of infliximab within 2 weeks for acute severe ulcerative colitis: A case report","volume":"101","author":"Alhalabi","year":"2022","journal-title":"Medicine"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e05205","DOI":"10.1002\/ccr3.5205","article-title":"Real-world evidence for subcutaneous infliximab (CT-P13 SC) treatment in patients with psoriatic arthritis during the coronavirus disease (COVID-19) pandemic: A case series","volume":"10","author":"Baraliakos","year":"2022","journal-title":"Clin. Case Rep."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(11)60839-2","article-title":"Fungal infections complicating tumor necrosis factor alpha blockade therapy","volume":"83","author":"Tsiodras","year":"2008","journal-title":"Mayo. Clin. Proc."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","article-title":"Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis","volume":"382","author":"Locatelli","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4103\/ijp.IJP_615_20","article-title":"Can emapalumab be life saving for refractory, recurrent, and progressive cytokine storm caused by COVID-19, which is resistant to anakinra, tocilizumab, and Janus kinase inhibitors","volume":"53","author":"Cure","year":"2021","journal-title":"Indian. J. Pharmacol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1093\/rheumatology\/kez087","article-title":"A systematic review and meta-analysis of infection risk with small molecule JAK inhibitors in rheumatoid arthritis","volume":"58","author":"Bechman","year":"2019","journal-title":"Rheumatology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jinf.2020.04.017","article-title":"Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact","volume":"81","author":"Cantini","year":"2020","journal-title":"J. Infect."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/978-3-319-91439-8_6","article-title":"Ruxolitinib","volume":"212","author":"Ajayi","year":"2018","journal-title":"Recent Results Cancer Res."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2352-3026(19)30156-5","article-title":"Ruxolitinib in adult patients with secondary haemophagocytic lymphohistiocytosis: An open-label, single-centre, pilot trial","volume":"6","author":"Ahmed","year":"2019","journal-title":"Lancet Haematol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.jaci.2020.05.019","article-title":"Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): A multicenter, single-blind, randomized controlled trial","volume":"146","author":"Cao","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1189\/jlb.4A1015-483R","article-title":"JAK\/STAT regulation of Aspergillus fumigatus corneal infections and IL-6\/23-stimulated neutrophil, IL-17, elastase, and MMP9 activity","volume":"100","author":"Taylor","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"26490","DOI":"10.1038\/srep26490","article-title":"Reducing hypoxia and inflammation during invasive pulmonary aspergillosis by targeting the Interleukin-1 receptor","volume":"6","author":"Gresnigt","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/art.41103","article-title":"Benefit of Anakinra in Treating Pediatric Secondary Hemophagocytic Lymphohistiocytosis","volume":"72","author":"Eloseily","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"ref_72","first-page":"CD015308","article-title":"Interleukin-1 blocking agents for treating COVID-19","volume":"1","author":"Davidson","year":"2022","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/jmv.26016","article-title":"Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia","volume":"93","author":"Mazzitelli","year":"2021","journal-title":"J. Med. Virol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ejim.2021.11.015","article-title":"Tocilizumab in severe COVID-19: A promise fulfilled","volume":"95","author":"Levi","year":"2022","journal-title":"Eur. J. Intern. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.cmi.2021.08.014","article-title":"Risk factors and outcome of pulmonary aspergillosis in critically ill coronavirus disease 2019 patients-a multinational observational study by the European Confederation of Medical Mycology","volume":"28","author":"Prattes","year":"2021","journal-title":"Clin. Microbiol. Infect."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Arastehfar, A., Carvalho, A., van de Veerdonk, F.L., Jenks, J.D., Koehler, P., Krause, R., Cornely, O.A., David, S.P., Lass-Florl, C., and Hoenigl, M. (2020). COVID-19 Associated Pulmonary Aspergillosis (CAPA)-From Immunology to Treatment. J. Fungi., 6.","DOI":"10.3390\/jof6020091"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s13054-021-03753-9","article-title":"Antifungal prophylaxis for prevention of COVID-19-associated pulmonary aspergillosis in critically ill patients: An observational study","volume":"25","author":"Hatzl","year":"2021","journal-title":"Crit. Care"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.diagmicrobio.2014.05.015","article-title":"Predictors of mortality in non-neutropenic patients with invasive pulmonary aspergillosis: Does galactomannan have a role?","volume":"80","author":"Russo","year":"2014","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1179\/joc.2011.23.5.290","article-title":"Invasive pulmonary aspergillosis in non-neutropenic patients: Analysis of a 14-month prospective clinical experience","volume":"23","author":"Russo","year":"2011","journal-title":"J. Chemother."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"e0009421","DOI":"10.1128\/CMR.00094-21","article-title":"Pathogenesis of Respiratory Viral and Fungal Coinfections","volume":"35","author":"Salazar","year":"2022","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"20834","DOI":"10.1038\/s41598-020-77641-7","article-title":"Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility","volume":"10","author":"Trecarichi","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Egger, M., Bussini, L., Hoenigl, M., and Bartoletti, M. (2022). Prevalence of COVID-19-Associated Pulmonary Aspergillosis: Critical Review and Conclusions. J. Fungi., 8.","DOI":"10.3390\/jof8040390"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1093\/cid\/ciaa1751","article-title":"EORTC\/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group","volume":"72","author":"Bassetti","year":"2021","journal-title":"Clin. Infect. Dis."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/6\/1364\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T23:23:28Z","timestamp":1760138608000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/12\/6\/1364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":83,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,6]]}},"alternative-id":["diagnostics12061364"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics12061364","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}